Peer Review History
Original SubmissionAugust 31, 2020 |
---|
PONE-D-20-27238 Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice PLOS ONE Dear Dr. Paust, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 23 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Junpeng Wang, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. To comply with PLOS ONE submissions requirements, please provide methods of sacrifice in the Methods section of your manuscript. 3. Please expand the acronym “TSRI” (as indicated in your financial disclosure) so that it states the name of your funders in full. *This information should be included in your cover letter; we will change the financial disclosure on the online submission form on your behalf.* [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: PONE-D-2027238 Overall: This is a nice brief report assessing immune cell populations and their associated cytokines during alcohol intoxication. It adds to the literature by assessing multiple tissues simultaneously and assessing for cell type origin of important mediators such as IFNg and IL-17. The manuscript is technically sound piece of scientific research with data that mostly supports the conclusions. However, the authors state these are changes due to their dependence model, though it cannot be determined if these are dependence-related changes or intoxication-related changes, since a single vapor exposure group is not included and dependent mice were sacrificed after a16h ethanol vapor session. Adding this important treatment group would help the field to understand acute vs chronic peripheral immune modulations in response to ethanol exposure. Otherwise, this is a nice and straight forward study that investigates cellular changes in IFNg and IL-17 expression in various tissues with ethanol treatment. Results: 1. Why were IL10tm1FLv mice used? Was this an attempt to obtain accurate IL-10 labeling? This should be noted in the text 2. It is important to emphasize that these findings are during intoxication as mice were sacrificed directly from the vapor chambers and cytokine changes vary during intoxication and withdrawal. 3. The gating scheme appears mostly correct. However, were T cells and NK cells gated from CD11b negative and CD11c negative populations? This is not clear from the table. This could be enhanced by a graphical example with sample flow data. 4. Have circulating endotoxin levels been measured with this vapor model? 5. Can the authors measure IFNg and IL-17 in serum by ELISA or Luminex? 6. Figure 1: subtle changes in T cells in blood and spleen, though reduced CD4 T cells seen in the spleen which should be in a main figure, along with the Th1/Th2 imbalance in the liver. a. Neutropenia is consistent with previous reports b. These changes could represent a migration of T cells from circulation (spleen represents circulating populations) into the liver. 7. The % of total IFNg+ CD45cells was increased in blood/spleen which is important. However a specific subtype of IFNg+ cells was not identified. Was this because IFNg was increased slightly (non-significant) across multiple cell types e.g. macrophages, neutrophils, and dendritic cells (Fig 2B)? In other words, if statistics are done on those 3 cell populations (e.g. ANOVA) is there an etoh effect? 8. Figure 2 can be a bit confusing to the reader as presented. I recommend placing panels D-J first (making them A-G) and having the data in A-C last as H-J. This way it is clear to the reader that IFNg is increased in B Cells, NK cells and blood neutrophils etc. Then the reader will see the relative distributions across cell types with the other data. As presented it is easy to be confused. 9. Figure 3 – same organizational comment as for figure 2 Discussion: 1. It is unclear from this study if this is a feature of alcohol dependence or if it is a feature of acute alcohol intoxication. In order to make the claim that these are dependence associated changes, a group of mice that just receive the single vapor exposure (16h) prior to sacrifice is needed. Pertinent references to include and mention: 1. Pasala et al 2015, PMID: 26695744 2. Gonzalez-Reimers et al 2012, PMID: 22510812 Reviewer #2: The manuscript titled “Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice” submitted by Fran K et al, evaluated the systemic immune modulations associated with the alcohol abuse and concluded that chronic alcohol consumption increases the pro-inflammatory responses. Although the pro-inflammatory effects of alcohol abuse are well established, this study was performed under non-pathological conditions. The overall manuscript is well written and I have the minor concerns. 1. Discussion and the result sections are redundant and the overall discussion is very lengthy. Moreover, the authors did not comment on the mechanistic insight into their findings. How this chronic inflammation may contribute to the pathologies associated with the organ systems they analyzed. 2. It is better to include the fluorescent plots to demonstrate the gating strategy instead of Table 2. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice PONE-D-20-27238R1 Dear Dr. Paust, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Junpeng Wang, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
Formally Accepted |
PONE-D-20-27238R1 Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice Dear Dr. Paust: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Junpeng Wang Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .